Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.diagmicrobio.2021.115370 http://scihub22266oqcxt.onion/10.1016/j.diagmicrobio.2021.115370 33744623!7954771!33744623     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 265.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Diagn+Microbiol+Infect+Dis 2021 ; 100 (3): 115370 Nephropedia Template TP {{tp|p=33744623|t=2021. Clinical evaluation of the antibody response in patients with COVID-19 using automated high-throughput immunoassays |pdf=|usr=}}{{33744623}} gab.com Text Clinical evaluation of the antibody response in patients with COVID-19 using automated high-throughput immunoassays JO: Diagn Microbiol Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=33744623 #FOAvip Several automated high-throughput immunoassays for detecting anti-SARS-CoV-2 antibodies by a semi-quantitative approach have been commercialized. In this study, we describe the timeline of the antibody response in patients with RT-PCR-confirmed COVID-19. A total of 292 sequential serum samples from 33 Japanese patients were retrospectively analyzed using four test kits for SARS-CoV-2: the Abbott SARS-CoV-2 IgG assay (Abbott), Elecsys(R) Anti-SARS-CoV-2 assay (Roche Diagnostic), and VITROS(R) Anti-SARS-CoV-2 Total and IgG assays (Ortho Clinical Diagnostics). All automated immunoassays could equivalently identify positive sera collected within 2 weeks after symptom onset (99.3%-100%). In addition, the S protein-based automated immunoassay, the VITROS(R) Anti-SARS-CoV-2 Total assay, may play a complementary role in evaluating passive antibody therapies or vaccines against SARS-CoV-2, although further research is required. Twit Text FOAVip Clinical evaluation of the antibody response in patients with COVID-19 using automated high-throughput immunoassays ????Diagn Microbiol Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=33744623 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33744623 #FOAvip English Wikipedia <ref>{{Cite pmid|33744623}}</ref> Clinical evaluation of the antibody response in patients with COVID-19 using automated high-throughput immunoassays #MMPMID33744623 Kubota K; Kitagawa Y; Matsuoka M; Imai K; Orihara Y; Kawamura R; Sakai J; Ishibashi N; Tarumoto N; Takeuchi S; Maesaki S; Maeda T Diagn Microbiol Infect Dis 2021[Jul]; 100 (3): 115370 PMID33744623show ga Several automated high-throughput immunoassays for detecting anti-SARS-CoV-2 antibodies by a semi-quantitative approach have been commercialized. In this study, we describe the timeline of the antibody response in patients with RT-PCR-confirmed COVID-19. A total of 292 sequential serum samples from 33 Japanese patients were retrospectively analyzed using four test kits for SARS-CoV-2: the Abbott SARS-CoV-2 IgG assay (Abbott), Elecsys(R) Anti-SARS-CoV-2 assay (Roche Diagnostic), and VITROS(R) Anti-SARS-CoV-2 Total and IgG assays (Ortho Clinical Diagnostics). All automated immunoassays could equivalently identify positive sera collected within 2 weeks after symptom onset (99.3%-100%). In addition, the S protein-based automated immunoassay, the VITROS(R) Anti-SARS-CoV-2 Total assay, may play a complementary role in evaluating passive antibody therapies or vaccines against SARS-CoV-2, although further research is required. |Adult[MESH] |Aged[MESH] |Antibodies, Viral/*blood[MESH] |COVID-19 Serological Testing/*methods[MESH] |COVID-19/*diagnosis/immunology[MESH] |Female[MESH] |High-Throughput Screening Assays[MESH] |Humans[MESH] |Immunoassay[MESH] |Kinetics[MESH] |Male[MESH] |Middle Aged[MESH] |Retrospective Studies[MESH] |SARS-CoV-2/*immunology/isolation & purification[MESH]Clinical evaluation of the antibody response in patients with COVID-19(epmc).pdf DeepDyve Pubget Overpricing